Please login to the form below

Not currently logged in
Email:
Password:

hypoglycaemia

This page shows the latest hypoglycaemia news and features for those working in and with pharma, biotech and healthcare.

FDA starts review of Sanofi’s oral type 1 diabetes drug

FDA starts review of Sanofi’s oral type 1 diabetes drug

The results suggest adding the drug to insulin therapy can improve glucose control as measured by haemoglobin A1c levels, with a reduced risk of potentially dangerous low blood sugar levels (hypoglycaemia).

Latest news

More from news
Approximately 2 fully matching, plus 93 partially matching documents found.

Latest Intelligence

  • Interview: Peter Meeus, Novo Nordisk Interview: Peter Meeus, Novo Nordisk

    end of last year and has demonstrated it is as effective in reducing blood glucose levels as is its rival Lantus from Sanofi, yet carries less risk of hypoglycaemia. ... In addition, Meeus highlighted a need to raise awareness among the healthcare

  • Interview: Pierre Chancel, Sanofi Diabetes Interview: Pierre Chancel, Sanofi Diabetes

    2 diabetes further reduce HbA1c, with the benefit of weight loss and limited risk of hypoglycaemia.”.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • How technology is shaping patient education

    The simulation showed the high impact of mild hypoglycaemia (low blood sugar) on a patient; it made the viewer ‘ feel’ the symptoms of hypoglycaemia in various scenarios through a typical day

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics